EX-23.1 3 a06-10506_1ex23d1.htm EX-23.1

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

We consent to the incorporation by reference in the Registration Statement on Form S-8 to be filed on or about May 5, 2006 pertaining to the 2000 Employee Stock Purchase Plan and the 2002 Non-Employee Directors’ Stock Option Plan of Isis Pharmaceuticals, Inc. of our reports dated March 7, 2006, with respect to the consolidated financial statements of Isis Pharmaceuticals, Inc., Isis Pharmaceuticals, Inc. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Isis Pharmaceuticals, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2005, filed with the Securities and Exchange Commission.

 

 

/s/  ERNST & YOUNG LLP

 

 

 

 

 

San Diego, California

 

May 2, 2006